Dova Pharmaceuticals | Senior Territory Business Manager, Pittsburgh Region
C: 412-897-8527 Email email@example.com
Chat with Matt
Dova is a growing specialty pharmaceutical company driven by our passion for building a high-value portfolio of differentiated medicines for patients with rare diseases. Every day we work to develop and commercialize solutions that can improve the health and well-being of patients in this community. Dova is a wholly-owned subsidiary of Swedish Orphan BiovitrumAB (publ) (Sobi).
DOPTELET® (avatrombopag) is a thrombopoietin receptor agonist (TPO-RA) indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.